Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hydrocodone bitartrate for chronic pain.

L Manchikanti1, S Atluri2, A M Kaye3

  • 1Pain Management Center of Paducah, Paducah, Kentucky, and University of Louisville, Louisville, Kentucky, USA. drlm@thepainmd.com.

Drugs of Today (Barcelona, Spain : 1998)
|August 12, 2015
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Recent preoperative imaging reveals aspiration risks.

Der Anaesthesist·2019
Same author

The Qualified Clinical Data Registry: A Pathway to Success within MACRA.

AJNR. American journal of neuroradiology·2017
Same author

Inadvertent intrathecal injections and best practice management.

Acta anaesthesiologica Scandinavica·2016
Same author

PQRS and the MACRA: Value-Based Payments Have Moved from Concept to Reality.

AJNR. American journal of neuroradiology·2016
Same author

Comment on Deckert et al.: A systematic review of the outcomes reported in multimodal pain therapy for chronic pain.

European journal of pain (London, England)·2016
Same author

ICD-10: History and Context.

AJNR. American journal of neuroradiology·2016

Hydrocodone bitartrate, a widely prescribed pain reliever, is under scrutiny for its high usage and potential for abuse in the U.S. This review explores its pharmacokinetics, safety, and efficacy.

Area of Science:

  • Pharmacology
  • Pain Management
  • Drug Abuse

Background:

  • Hydrocodone bitartrate is the most prescribed drug for pain in the U.S., accounting for over 135 million prescriptions in 2012.
  • The U.S. consumes 99% of the global hydrocodone supply, raising concerns about its widespread availability and potential for misuse.
  • Despite its common use, clinical efficacy studies for short-acting hydrocodone combinations in chronic pain are lacking.

Purpose of the Study:

  • To review the evolution of hydrocodone as a widely used and controversial medication in the U.S.
  • To examine the pharmacokinetics, pharmacodynamics, safety, and efficacy of hydrocodone.
  • To provide an overview of regulatory changes, including its rescheduling and acetaminophen dosage limits.

Main Methods:

  • Literature review of hydrocodone's history, usage patterns, and clinical data.
Keywords:
AbuseAcetaminophenAddictionHydrocodoneMisuseOpioids

Related Experiment Videos

  • Analysis of pharmacokinetic and pharmacodynamic properties.
  • Examination of safety and efficacy profiles based on available studies and regulatory information.

    • Main Results:

    • Hydrocodone's significant role in pain management is contrasted with its high abuse potential, contributing to the opioid crisis.
    • Regulatory actions, including rescheduling to Schedule II and acetaminophen dosage limits, reflect concerns over its safety.
    • Limited clinical data exists for short-acting hydrocodone formulations in chronic pain management.

    Conclusions:

    • Hydrocodone remains a critical but controversial analgesic in the U.S.
    • Further research is needed to establish clear efficacy guidelines, particularly for chronic pain.
    • Understanding its pharmacokinetics, pharmacodynamics, and safety is crucial for responsible prescribing and abuse prevention.